Literature DB >> 1089999

Glucagon: role in the hyperglycemia of diabetes mellitus.

R Dobbs, H Sakurai, H Sasaki, G Faloona, I Valverde, D Baetens, L Orci, R Unger.   

Abstract

Glucagon suppression by somatostatin reduces or abolishes hyperglycemia in dogs made insulin-deficient by somatostatin, alloxan, or total pancreatectomy. This suggests that the development of severe diabetic hyperglycemia requires the presence of glucagon, whether secreted by pancreatic or newly identified gastrointestinal A cells, as well as a lack of insulin. Glucagon suppression could improve therapeutic glucoregulation in diabetes.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1089999     DOI: 10.1126/science.1089999

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  66 in total

1.  Immuno-fluorescent reactivity to anti-somatostatin in the gastro-intestinal mucosa of the dog.

Authors:  C Rufener; M P Dubois; F Malaisse Lagae; L Oric
Journal:  Diabetologia       Date:  1975-08       Impact factor: 10.122

2.  Distribution and properties of glucagon immunoreactivity in the digestive tract of various mammals: an immunohistochemical and immunochemical study.

Authors:  L I Larsson; J Holst; R Håkanson; F Sundler
Journal:  Histochemistry       Date:  1975-09-29

3.  A combined radioimmunoassay for glucagon and insulin.

Authors:  V Leclercq-Meyer; J Marchand; O Rebolledo; W J Malaisse; R Leclercq
Journal:  Diabetologia       Date:  1975-10       Impact factor: 10.122

Review 4.  Glucagonocentric restructuring of diabetes: a pathophysiologic and therapeutic makeover.

Authors:  Roger H Unger; Alan D Cherrington
Journal:  J Clin Invest       Date:  2012-01-03       Impact factor: 14.808

5.  Plasma glucagon immunoreactivity in a totally pancreatectomized patient.

Authors:  M L Villanueva; J A Hedo; J Marco
Journal:  Diabetologia       Date:  1976-12       Impact factor: 10.122

6.  Effect of glucagon antibodies on plasma glucose, insulin and somatostatin in the fasting and fed rat.

Authors:  K Tan; D Tsiolakis; V Marks
Journal:  Diabetologia       Date:  1985-07       Impact factor: 10.122

7.  Glucagon receptor antagonism improves islet function in mice with insulin resistance induced by a high-fat diet.

Authors:  M Sörhede Winzell; C L Brand; N Wierup; U G Sidelmann; F Sundler; E Nishimura; B Ahrén
Journal:  Diabetologia       Date:  2007-05-04       Impact factor: 10.122

8.  Ontogenetic appearance of immunoreactive endocrine cells in rat pancreatic islets.

Authors:  M Yoshinari; S Daikoku
Journal:  Anat Embryol (Berl)       Date:  1982-09

9.  Inhibition by somatostatin of carbamylcholine-induced gastrin and glucagon release from the isolated perfused canine stomach.

Authors:  P J Lefebvre; A S Luyckx; A H Brassinne
Journal:  Gut       Date:  1981-10       Impact factor: 23.059

10.  Effects of physiologic levels of glucagon and growth hormone on human carbohydrate and lipid metabolism. Studies involving administration of exogenous hormone during suppression of endogenous hormone secretion with somatostatin.

Authors:  J E Gerich; M Lorenzi; D M Bier; E Tsalikian; V Schneider; J H Karam; P H Forsham
Journal:  J Clin Invest       Date:  1976-04       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.